tiprankstipranks
Trending News
More News >
Aprea Therapeutics, Inc. (APRE)
:APRE
US Market

Aprea Therapeutics (APRE) Income Statement

Compare
464 Followers

Aprea Therapeutics Income Statement

Last quarter (Q3 2024), Aprea Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Aprea Therapeutics's net income was $-3.78M. See Aprea Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 583.23K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 576.18K$ -186.44K$ -271.68K$ -229.61K
Operating Expenses
$ 15.82M$ 16.05M$ 37.37M$ 37.45M$ 52.81M
Depreciation and Amortization
$ 0.00-$ 186.44K$ 271.68K$ 229.61K
EBITDA
$ -14.32M$ -14.28M$ -112.48M$ -36.86M$ -53.25M
Operating Income
$ -14.32M$ -15.47M$ 38.18M$ -38.04M$ -52.15M
Other Income/Expenses
$ 1.36M$ 1.19M$ -75.29M$ 319.05K$ -667.60K
Pretax Income
$ -12.96M$ -14.29M$ -112.66M$ -37.13M$ -53.48M
Net Income
$ -12.96M$ -14.29M$ -224.88M$ -36.54M$ -53.92M
Per Share Metrics
Basic EPS
$ -2.35$ -3.95$ -2.71K$ -34.33$ -51.02
Diluted EPS
$ -2.35$ -3.95$ -2.71K$ -34.33$ -51.02
Weighted Average Shares Outstanding
5.51M 3.62M 82.85K 1.06M 1.06M
Weighted Average Shares Outstanding (Diluted)
5.51M 3.62M 82.85K 1.06M 1.06M
Currency in USD

Aprea Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis